A startup studio creates new startups from the ground up.

Applied Materials is a world-wide largest Semiconductor and Display equipment manufacturer.

AIxMed, Inc. is a technology company focus on leveraging Artificial Intelligence (A.I.) in Oncology field to accelerate Precision Medicine. AIxMed provides comprehensive AI solutions from laboratory and clinical cell-level applications in precision medicine. AIxMed provides a client-specific cell level image analysis based on proprietary algorithms based on machine learning. AIxMed provides researchers and clinicians with a tool which helps increases precision, decreases labor work, workflow optimization and enabling better decisions from laboratories to clinical fields around the world.

Algen Biotechnologies, a therapeutic discovery company, is building an intelligent platform to decode functional gene networks for cancer target discovery.

AB Biosciences, Inc. is dedicated to engineering and production of niche protein molecules that enhance and accelerate biomedical research and drug developmeny. Our ultimate goal is to generate biologics for diagnostic and therapeutic purposes.

We are developing proprietary biologics/ antibodies to harness the power of the immune system to treat and cure cancer.  We focus on the most powerful biological mechanisms that we believe drive disease pathophysiology in immuno-oncology

Acepodia is developing cancer immunotherapy based on our novel ACCTM (Antibody-Cell conjugation) technology platform enable antibodies of choice to be covalently attached to immune cells (e.g. NK cells). The arming Antibody-Conjugated Effector cells (ACETM) direct and evoke immune responses to eradicate cancer cells. The mission of Acepodia, Inc. is to develop safe, effective, and affordable immunotherapeutic medicines targeting diseases with significant unmet medical needs, with our current primary focus in oncology. Our collaboration ranges from academies, hospitals to industries. 

AiCare is proud to present its first-generation cloud-enabled, machine learning analytic and IoT-enabled, intelligent sensor technology for, “Intelligent senior living” and Precisions Care. This innovation in artificial intelligence for senior care provides personalized security, safety, and prevention to empower the daily lives of the senior citizens in nursing home. The machine learning algorithms, will measure and predict the pattern of each individual’s daily activity and behavior. Any deviation from each senior citizen’s daily routine, including location, mobility, social interactivity, and vital signs are readily tracked in real-time. This capability enables precision tracking of any anomaly from the normal values, which will detect wandering, fall, and abnormal behavior to trigger a health-watch alert. This technology is powered by our proprietary smart sensors, individualized big data of human behavior, personalized function-specific interactive software, and intelligent machine-learning analytics. This comprehensive platform offers an effective convergence of eHealth, artificial intelligence, and telemedicine technology over the Internet-enabled mobile devices to leverage the economical, low-cost, and pervasive technology to personalize safety, security, and health and provide individualized intelligent care to promote graceful aging.

AbVision, Inc. (AVI) previously the Drug Discovery Group of BioVision Inc., is a privately held biopharmaceutical company headquartered in the San Francisco Bay Area. AVI’s most advanced drug discovery efforts aim to develop pipelines of cancer and infectious disease therapeutics that harness the natural power of the immune system to bring first-in-class and best-in-class drugs to the world.

Amgen, which is one of the world's largest biotechnology companies, was established in Newbury Park, California in 1980.

Biopharma

BioLegend enables life science discovery from research to cure by providing world-class quality products at an outstanding value, with superior customer service and technical support. Our focus on cutting-edge research and diagnostic reagents has established us as a global leader in immunology, cancer, neuroscience, cell biology, proteogenomics, stem cells, and other emerging segments. To learn more, visit www.biolegend.com.

Clinicai brings biotechnology to our daily life for health monitoring and early disease detection. We are building a non-invasive smart toilet platform empowered by biotechnology, sensor networks, and artificial intelligence to continuously track people's health for early detection of colorectal cancer and gastrointestinal diseases. Our technology provides digital, continuous, contactless, and comfortable health monitoring via everyday activities in the bathroom.

deeplearning.ai is an educational hub that provides online courses, resources, and a community for people who want to learn how to build or work with AI. The company was founded in 2017 by Dr. Andrew Ng.

Equalearning, an interactive mobile solution provider (IMSP), leveraged the ubiquity of tablets and smartphones and created an interactive mobile platform that is instantly deployable, requires little capital expense, and can improve learning outcomes immediately.​  ​  ​Based upon our platform, Equalearning provides 8 mobile first SaaS options – Educational Institution Mobile Companion, Educational Mobile Publishing Solution, Structured Mobile Tutoring, Corporate Training & Online Workshop Solution, Mobile Coaching Solution, Embedded Internet of Things (IoT) Solution, Offline Interactive Teaching/Training Solution, and NGO Training Solution.  We value Accessibility, Affordability, and Compatibility; the advantages of our technology include uninterrupted offline capability, hassle-free hardware integration, and efficient cost-effective development.

Genentech, Inc., is a biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche.

We are a contract research organization, provide strategic clinical services including project management, monitoring , data management, medical writing, biostatistics, regulatory, and remote visits.

ironSource builds technologies that help app developers take their apps to the next level, including the industry’s largest in-app video network, a robust mobile ad mediation platform, and a data-driven user acquisition platform. the The ironSource Aura platform gives advertisers an unprecedented opportunity to connect with millions of users when they’re primed to install new apps. ironSource Aura creates new engagement touchpoints both as part of a new device setup experience, and throughout the lifetime of the device.

InnovArt is a Taiwan and LA based startup integrating Tech/ Design/ Business/ and UX talents together to create innovative products which also compliments the user’s lifestyle,and our ultimate goal is to enhance human connectivity through future mobility.

International Business Machines Corporation (IBM) is an American multinational information technology company. Comapny current strategy is software and service as the congnitive service on the cloud.

Founded in 1994 and experts in providing comprehensive and premium IP Media platforms and solutions, InfoValue is recognized for  innovations and advances in IPTV technology that has set the pace in performance, scalability and intelligence. InfoValue delivers IPTV solutions and products to hospitality, healthcare, education, enterprise, government and telecomm markets.

Jasper Display Corp., operations started in 2010, is a leading designer of SLM (Spatial Light Modulators) and has successfully developed and brought to the marketplace several new, very high speed Full HD (FHD) microdisplays and a microdisplay controller, establishing a line of new LCoS products to support color-sequential single-microdisplay operated at FHD resolution and high frame rate. In addition, Jasper Display has the world’s smallest Ultra HD (UHD) microdisplay in the world. Jasper Display’s newest addition, the OCM, will now add an ASIC controller to drive the full line of microdisplays from FHD to UHD microdisplays.

Kneron, the leading provider of edge AI solutions, was founded in San Diego in 2015. It provides software and hardware integrated AI solutions, including Neural processing unit (NPU), a dedicated edge AI device processor and a range of visual recognition software. Kneron currently has offices in San Diego, Taipei, Shenzhen and Zhuhai and has partners and customers around the world.  Kneron announced the completion of series A financing in November, 2017. Alibaba Entrepreneurs Fund and CDIB Capital Group are the lead investors, and Himax Technologies Inc, Qualcomm, Thundersoft, Sequoia Capital (sub fund: Cloudatlas), and CY ZONE are co-investors. Kneron completed its series A1 financing led by Horizons Ventures, a venture capital firm founded by Ka-shing Li, in May 2018.

Transportation Engineering planning/design

LIGHTEL is an advanced technology company located in Seattle to service the Fiber Optic & Photonics industries worldwide. The new focus is to develop Hi-power (KW) technologies for Fiber Laser applications to serve the Industry 4.0., IMS (Intelligent Manufacturing System) and Defense sectors.

Life Science Nation is a global matching platform for early stage buyers and sellers across the domains of Biotech, Medtech, Diagnostics and Healthcare IT. LSN curates two databases: a buy-side of global early stage investors and a sell-side of global technology assets. LSN also offers a sourcing and ranking service for clients who need to source and rank technology assets for channel and pipeline development. The RESI Conference Series, which stages the Redefining Early Stage Investments (RESI) Conference that is held five times a year in San Francisco, Toronto, Boston and New York City (soon to expand to Europe and Asia). The Entrepreneurs Academy, which offers classes and workshops on preparing companies for fundraising.

Microsoft Corporation is an American multinational corporation headquartered in Redmond, Washington, that develops, manufactures, licenses, supports and sells computer software, consumer electronics and personal computers and services.

GAIN WORK EXPERIENCE IN RISING SILICON VALLEY EARLY STAGE STARTUP!!   mFluiDx is aiming to develop the world’s lowest cost, automated point-of-care DNA diagnostic assay for small clinics.  In small clinics, such as primary care out-patient clinics, disease diagnosis is typically done by observing symptoms or using paper-strip antibody tests. However, these methods have poor sensitivity compared to DNA diagnostics.  Highly sensitive molecular DNA tests (PCR) are not often used because of cost and the need to send tests off-site resulting in a slow turnaround time (several days).  mFluiDx is a UC Berkeley startup developing Gates Foundation funded low-cost microfluidic diagnostic technologies capable of on-site multi-target isothermal DNA detection of infectious diseases with simple operation and ~100X lower cost than PCR setups. We aim to create assays that can be deployed in decentralized settings, are as simple and cheap as paper tests, yet have DNA level sensitivity for onsite diagnosis.  mFluiDx has been selected as one of the top 20 finalists from a global competition of 900 startups at Techcrunch’s Startup Battlefield, it has participated the world’s best biotech startup accelerator (Indiebio Accelerator). It was selected as top 6 early stage startups among all 10 UC campuses. We look forward to work with trainees that can potentially transition into full time for several years after LEAP program and is excited in joining mFluiDx’s vision for next generation diagnostics.    More info can be found in this video link (CITRIS Foundry demo day pitch): https://youtu.be/WSEKyGikUKU 

We are innovators of a higher standard, using cutting-edge technologies to lead the medical device industry forward. Niche Biomedical Inc. is dedicated to developing revolutionary bioelectronic medicines, employing the best engineers, leading scientists and medical professionals to improve human health by targeting an array of diseases and organ injuries as well as the central, peripheral, autonomic, and enteric nervous systems.

Naval Group is an international high-tech company and one of the few global leaders in defence naval systems whose skills cover the whole of the production chain for complex programmes. Naval Group uses its extraordinary know-how and unique industrial resources to meet its customers’ requirements.

Onyx Healthcare USA Inc. is a professional medical IT company in providing trusted, innovative products, customer-centric design services and medical pc solutions. 

Omega Optics Inc. was incorporated in Austin, Texas in 2002, focusing on technol¬ogy and product development in photonics, bio- and chemical sensing and telecommunication technologies. Since its initia¬tion, Omega Optics has been actively involved in optical communications/interconnects research/development work where arrays of products have been developed from internal R&D and SBIR/STTR efforts. Omega Optics creates customer-oriented active and passive guided wave optics compo¬nents.  We have over 20 US patents to further commercialize the early cancer detection system using silicon CMOS technology.  A fully automated system is currently commercially available.

About PfizerGood health is vital to all of us， and finding sustainable solutions to the most pressing health care challenges of our world cannot wait. That's why we at Pfizer are committed to applying science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe， effective and affordable medicines and related health care services to the people who need them.We have a leading portfolio of products and medicines that support wellness and prevention， as well as treatment and cures for diseases across a broad range of therapeutic areas; and we have an industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of our time， like Alzheimer's disease and cancer.To ensure we can continue to deliver on our commitments to the patients， customers and shareholders who rely on us， we are focused on improving the way we do business; on operating with transparency everything we do; and on listening to the views of all of the people involved in health care decisions. Through working in partnership with everyone from patients to health care providers and managed care organizations to world governments and non-governmental organizations, our goal is to ensure that people everywhere have access to innovative treatments and quality health care.  (Pfizer.com)

PharmaEssentia Corporation (Taipei Exchange:6446) is a fully integrated global biopharmaceutical company delivering efficacious, safe and cost-effective therapeutic products for the treatment of human diseases while aiming to bring long lasting value to stakeholders  PharmaEssentia was founded in 2003 by a group of Taiwanese-American executives and high-ranking scientists from leading U.S. biotechnology and pharmaceutical companies in order to develop treatments for myeloproliferative neoplasms, hepatitis and other diseases. The company is committed to the improvement of health and quality of life for patients suffering from these diseases.   The Company’s world-class cGMP biologics facility in Taichung is certified by the Taiwan Food and Drug Administration (TFDA) and is designed and operated to be compliant with all U.S. FDA and EMA requirements.

Skopai provides an AI-based platform to objectively evaluate any startup anywhere in the world. We use the state-of-the-art Machine Learning techniques to provide a 360-degree, structured view of startups.

BRISC is a small non-profit reserach institute located in San Diego North County, California. Our mission is to conduct pre-clinical research aimed at understanding, preventing and curing human disease. Our projects include studies on diabetes and other autoimmune diseases, cancer, vaccines,  infections diseases and birth defects.

Doing the business of developing and producing the  medical devices for breast cancer prognosis and diagnosis. Dedicates to R&D, product introductions, 

Taboola enables over 1.4B people to discover what’s interesting and new at the moments they’re most ready to explore. Powered by Deep Learning, AI, and a large dataset, Taboola’s discovery platform creates new monetization, audience and engagement opportunities for digital properties, including publishers, mobile carriers and handset manufacturers. Advertisers use Taboola to reach their target audience when they’re most receptive to new messages, products and services.

Some of the most innovative digital properties in the world have long term, exclusive relationships with Taboola, including CNBC, NBC News, USA TODAY, BILD, Sankei, Huffington Post, Microsoft, Business Insider, The Independent, and Le Figaro. Taboola, now over 1,000 people globally, is headquartered in New York City with offices in Mexico City, São Paulo, Los Angeles, London, Berlin, Madrid, Paris, Tel Aviv, New Delhi,Bangkok, Beijing, Shanghai, Istanbul, Seoul, Tokyo, and Sydney.

TTI is a leader in cutting edge mmWave Phased-Array Antenna Technology. Pioneer developer and demonstrator of high performance, compact, mobile mmWave antenna solutions, based on advanced CMOS, high performance substrate, and packaging technology for 5G cellular and sateliite markets.  

Vivo Capital is a healthcare focused investment firm formed in 1996 with over $3 billion under management. Vivo Capital is currently making investments from its $750M eighth fund into promising private and public healthcare companies in the U.S. and Greater China, from its $635M Opportunity fund into promising public healthcare companies, and from its $100M PANDA fund into promising early-stage innovative healthcare companies. Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising therapeutic products at all stages in the U.S. and revenue stage companies in Greater China. Vivo Capital has offices in Palo Alto, California, Beijing, Shanghai and Taipei. With extensive scientific expertise and operating experience in healthcare, Vivo makes investment decisions for the Funds and helps its portfolio companies develop corporate strategy, facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth. Vivo’s current portfolio includes more than 80 private and public biotechnology companies in the areas of biopharmaceuticals, specialty pharmaceuticals, and medical devices.

Vizuro operates as an AI incubator. We utilize our proprietary technology and managed, data-science-as-a-service platform to empower clients to quickly deploy our standard or bespoke solutions in expedited timeframe, then operate them with self-service and augmented support from us. Since the inception, we have developed groundbreaking AI technologies in radiology, marketing analytics, bioinformatics, semiconductor, etc., with reputable clientele and partners.